GlassScriptPhysician profile
Elena Feldman
NPI 1679526040
$3,790.63
in general payments reported to CMS, 2019-2025
18 companies · $622 in 2025
The $622 reported for 2025 was more than what 82% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $804 · 2020: $403 · 2021: $311 · 2022: $241 · 2023: $675 · 2024: $734 · 2025: $622.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,030.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,030.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $486.32 | 2023-2025 | Xiidra, Miebo, Vyzulta |
| Alcon Vision LLC | $480.17 | 2022-2025 | Rocklatan, Tryptyr, Eysuvis |
| Johnson & Johnson Vision Care, INC. | $431.31 | 2019-2025 | Acuvue |
| Eyevance Pharmaceuticals LLC | $359.03 | 2020-2022 | |
| Novartis Pharmaceuticals Corporation | $279.24 | 2019-2023 | |
| Biotissue Holdings INC. | $245.18 | 2023-2024 | |
| Allergan, INC. | $239.80 | 2019-2021 | |
| Tarsus Pharmaceuticals, INC. | $225.37 | 2024-2025 | Xdemvy |
| Aerie Pharmaceuticals, INC. | $223.16 | 2019-2021 | |
| Sun Pharmaceutical Industries INC. | $197.94 | 2019-2025 | Cequa |
| Shire North American Group INC | $194.32 | 2019 | |
| Abbvie INC. | $126.37 | 2022-2024 | |
| Dompe US, INC. | $110.67 | 2024-2025 | Oxervate |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $96.88 | 2019-2020 | |
| Carl Zeiss Meditec Ag | $38.80 | 2020 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Thea Pharma INC. | $22.18 | 2023 | Iyuzeh |
| Sight Sciences, INC. | $19.53 | 2020 | |
| Cumberland Pharmaceuticals, INC. | $14.36 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elena Feldman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.